BEVERLY, Mass.--(BUSINESS WIRE)-- American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider of dialysis services, announced today that it will release its third quarter 2017 financial results after the market close on Tuesday, November 14, 2017, to be followed by a conference call on Wednesday, November 15, 2017 at 9:00 a.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201) 689-8029. A replay will be available one hour after the call and can be accessed by dialing (877) 660-6853, or for international callers (201) 612-7415. The conference ID for the live call and the replay is 13672151. The replay will be available until November 22, 2017.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the company’s website at http://ir.americanrenal.com/. The online replay will be available for a limited time beginning immediately after the call.
About American Renal Associates
American Renal Associates Holdings, Inc. (NYSE: ARA) is a leading provider of outpatient dialysis services in the United States. As of June 30, 2017, ARA operated 217 dialysis clinic locations in 25 states and the District of Columbia serving approximately 15,000 patients with end stage renal disease. ARA operates exclusively through a physician joint venture model, in which it partners with approximately 386 local nephrologists to develop, own and operate dialysis clinics. ARA’s Core Values emphasize taking good care of patients, providing physicians with clinical autonomy and operational support, hiring and retaining the best possible staff and providing best practices management services. For more information about American Renal Associates, visit www.americanrenal.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171031006409/en/
American Renal Associates Holdings, Inc.
Darren Lehrich, 978-522-6063
SVP of Strategy & Investor Relations
Source: American Renal Associates Holdings, Inc.